To access this element change to forms mode OFF
Grant Award View - GA58864
Development of a novel drug class for the treatment of Plasmodium...
GA ID:
GA58864
Agency:
National Health and Medical Research Council (NHMRC)
Approval Date:
1-Aug-2019
Publish Date:
30-Sep-2019
Category:
Medical Research
Grant Term:
1-Jan-2020 to 31-Dec-2021
Value (AUD):
$445,920.00
(GST inclusive where applicable)
One-off/Ad hoc:
No
Aggregate Grant Award:
No
PBS Program Name:
NHMRC 18/19 1.1 Health and Medical Research
Grant Program:
Development Grants
Grant Activity:
Development of a novel drug class for the treatment of Plasmodium falciparum malaria
Purpose:
Recent gains made in malarial control are now threatened by the emergence of antimalarial drug resistance, which is causing up to 50 percent treatment failure. New drugs are needed that have novel mechanisms of action, are fast acting and show activity against all known resistant parasite strains. We have identified a class of compounds that fits these criteria and propose to develop them as drug leads.
GO ID:
GO Title:
NHMRC Development Grants 2019 for funding in 2020
Internal Reference ID:
GNT1171794
Selection Process:
Targeted or Restricted Competitive
Confidentiality - Contract:
Yes
Confidentiality Reason(s) - Contract:
Privacy Act 1988
Intellectual property
Intellectual property
Confidentiality - Outputs:
Yes
Confidentiality Reason(s) - Outputs:
Intellectual property
Grant Recipient Details
Recipient Name:
University of Melbourne
Recipient ABN:
84 002 705 224
Grant Recipient Location
Suburb:
Parkville
Town/City:
Parkville
Postcode:
3052
State/Territory:
VIC
Country:
AUSTRALIA
Grant Delivery Location
State/Territory:
VIC
Postcode:
Country:
AUSTRALIA